KeyBank National Association
AGN

KeyBank National Association’s Allergan Inc AGN Stock Holding History

KeyBank National Association’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,330
Closed -$1.98M – 1287
2014
Q4 		$1.98M Buy
9,330
+251
+3% +$49.9K 0.01% 394
2014
Q3 		$1.62M Sell
9,079
-843
-8% -$140K 0.01% 461
2014
Q2 		$1.68M Sell
9,922
-723
-7% -$113K 0.01% 472
2014
Q1 		$1.32M Sell
10,645
-165
-2% -$20.1K 0.01% 545
2013
Q4 		$1.2M Sell
10,810
-9,600
-47% -$917K 0.01% 578
2013
Q3 		$1.85M Sell
20,410
-157,130
-89% -$14.1M 0.01% 419
2013
Q2 		$17.1M Buy
+177,540
New +$18.4M 0.06% 349

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

KeyBank National Association's AGN Position: Q1 2015 in Review

KeyBank National Association sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 9,330 shares — an estimated $1.98M sold.

KeyBank National Association first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $17.1M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • KeyBank National Association reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • KeyBank National Association sold 9,330 Allergan Inc shares in Q1 2015, an estimated $1.98M.
  • KeyBank National Association first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • KeyBank National Association's Allergan Inc position peaked at $17.1M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on KeyBank National Association's 13F filing for Q1 2015, filed 7 May 2015.